Breton Morgan, MD
Family Medicine · Pt Pleasant, WVNPI 1508897919
Payments from drug & device makers
Across 115 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$615
- AbbVie$421
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$321
- Exact Sciences$92
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
- Novo Nordisk$81
- plus $297 from 13 others
What the payments were for
- Food & beverage$1,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 38 | $615 |
| AbbVie | 27 | $421 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $321 |
| Exact Sciences | 3 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $88 |
| Novo Nordisk | 5 | $81 |
| Novartis | 3 | $51 |
| Lundbeck LLC | 3 | $50 |
| Intra-sana Laboratories | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
| Insulet Corporation | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Abbott | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $12 |
How this compares
$1,914 in reported general payments places this provider in the 75th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 140 | $225,383 |
| OzempicSemaglutide | 81 | $130,092 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $69,948 |
| EliquisApixaban | 58 | $55,837 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $39,982 |
| XareltoRivaroxaban | 25 | $35,691 |
| EntrestoSacubitril/Valsartan | 18 | $27,253 |
| LinzessLinaclotide | 18 | $25,879 |
| TrulicityDulaglutide | 15 | $22,735 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $21,214 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $20,522 |
| GemtesaVibegron | 13 | $16,206 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $11,058 |
| Dexlansoprazole DrDexlansoprazole | 22 | $6,336 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $6,049 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $81 | $130,09281 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $615 | $91,16171 claims |
| PfizerEliquis | $15 | $55,83758 claims |
| NovartisEntresto | $51 | $27,25318 claims |
| AbbVieLinzess | $421 | $25,87918 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $12 | $16,20613 claims |
| Boehringer IngelheimCombivent Respimat | $15 | $5,94912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Pt Pleasant
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.